Call for proposal

  Thursday 15 March 2018


IMI 2 - Call 8

The Innovative Medicines Initiative (IMI) is working to improve health by speeding up the development of, and patient access to, innovative medicines, particularly in areas where there is an unmet medical or social need. It does this by facilitating collaboration between the key players involved in healthcare research, including universities, the pharmaceutical and other industries, small and medium-sized enterprises (SMEs), patient organisations, and medicines regulators. IMI is a partnership between the European Union (represented by the European Commission) and the European pharmaceutical industry (represented by EFPIA, the European Federation of Pharmaceutical Industries and Associations).

Submission deadline: 15 March 2018

This Call, the second under the Ebola+ programme, provides an opportunity to capture emerging scientific advances and to progress those rapidly into healthcare interventions. As such, the key deliverables of projects funded under the Ebola+ programme must be outputs that will increase our preparedness to react to future outbreaks of Ebola and other filoviral haemorrhagic fevers.

For more information and application : Please have a look at the IMI's website and the online webinar.


Contact Research Office

Accessibility General public

Admittance Free